Month: September 2023

Sep 30 2023

Uncategorized

ED visits for cannabis use linked to higher rates of schizophrenia — especially in young men – Ottawa Citizen

by Clinical Editor

No Comments

ED visits for cannabis use linked to higher rates of schizophrenia — especially in young men  Ottawa Citizen

Sep 30 2023

Uncategorized

Karuna Therapeutics files for FDA approval for schizophrenia treatment

by Clinical Editor

No Comments

Karuna Therapeutics has announced the submission of a new drug application (NDA) to the US Food and Drug Administration for KarXT (xanomeline-trospium), an antipsychotic drug developed for the …

Sep 30 2023

Uncategorized

Inglewood mayor speaks on body-worn cameras after police fatally shoot man with schizophrenia

by Clinical Editor

No Comments

“Body cameras are not be all end all,” Inglewood Mayor James Butts said. “A well-trained, well-disciplined police force with reverence for life — that’s what you need in our communities.”...

Sep 30 2023

Uncategorized

Will New Antipsychotics for Schizophrenia Be Game Changers?

by Clinical Editor

No Comments

In a previous article, I made the case that little has changed within the antipsychotic drug landscape over the past 70 years since the only effective medications for the treatment...

Sep 30 2023

Uncategorized

New Schizophrenia Treatments Are Coming: Don’t Panic

by Clinical Editor

No Comments

At the recent Psych Congress 2023, a session titled “State of the Science: Focus on Schizophrenia” was presented by Peter J. Weiden, MD, a clinical professor of psychiatry at the...

Sep 30 2023

Uncategorized

Brain damage linked to schizophrenia may spread as condition develops

by Clinical Editor

No Comments

Brain scans show loss of tissue starting in small areas when people first experience psychosis, and following neural highways until later it encompasses wider regions of the brain …

Sep 29 2023

Uncategorized

Karuna Submits Highly Anticipated NDA for KarXT in Schizophrenia – BioSpace

by Clinical Editor

No Comments

Karuna Submits Highly Anticipated NDA for KarXT in Schizophrenia  BioSpace

Sep 29 2023

Uncategorized

ED visits for cannabis use linked to higher rates of schizophrenia — especially in young men – Ottawa Citizen

by Clinical Editor

No Comments

ED visits for cannabis use linked to higher rates of schizophrenia — especially in young men  Ottawa Citizen

Sep 29 2023

Uncategorized

Karuna’s new schizophrenia drug reaches FDA’s desk – FierceBiotech

by Clinical Editor

No Comments

Karuna’s new schizophrenia drug reaches FDA’s desk  FierceBiotech

Sep 29 2023

Uncategorized

New Schizophrenia Treatments Are Coming: Don’t Panic

by Clinical Editor

No Comments

At the recent Psych Congress 2023, a session titled “State of the Science: Focus on Schizophrenia” was presented by Peter J. Weiden, MD, a clinical professor of psychiatry at the...